Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study. [electronic resource]
Producer: 20150930Description: 568-575 p. digitalISSN:- 1933-2874
- Adult
- Aged
- Apolipoproteins A -- blood
- Apolipoproteins B -- blood
- Biological Products -- immunology
- China
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Drugs, Chinese Herbal -- administration & dosage
- Dyslipidemias -- diagnosis
- Female
- Gastrointestinal Diseases -- etiology
- Humans
- Hypolipidemic Agents -- administration & dosage
- Lovastatin -- therapeutic use
- Male
- Middle Aged
- Placebos -- administration & dosage
- Triglycerides -- blood
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.